デフォルト表紙
市場調査レポート
商品コード
1463892

睡眠時無呼吸用デバイス市場- 世界の産業規模、シェア、動向、機会、予測、タイプ別、治療デバイス別、診断デバイス別、適応症タイプ別、エンドユーザー別、地域別、競合別、2019年~2029年

Sleep Apnea Device Market - Global Industry Size, Share, Trends, Opportunity and Forecast, By Type, By Therapeutic Devices, By Diagnostic Devices, By Indication Type, By End User, By Region and Competition, 2019-2029F

出版日: | 発行: TechSci Research | ページ情報: 英文 183 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.89円

こちらのレポートには、数時間(ご購入金額の10%)分のアナリストへの質問/追加調査サービスが含まれております。

睡眠時無呼吸用デバイス市場- 世界の産業規模、シェア、動向、機会、予測、タイプ別、治療デバイス別、診断デバイス別、適応症タイプ別、エンドユーザー別、地域別、競合別、2019年~2029年
出版日: 2024年04月15日
発行: TechSci Research
ページ情報: 英文 183 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 目次
概要

睡眠時無呼吸用デバイスの世界市場は2023年に46億3,000万米ドルと評価され、2029年までのCAGRは6.53%で、予測期間中に力強い成長が予測されています。

睡眠時無呼吸用デバイスの世界市場は、より広範な医療機器産業の中で急成長している分野であり、睡眠時無呼吸として知られる一般的な睡眠障害に対処することを目的としています。睡眠時無呼吸症候群は、睡眠中の呼吸の中断を特徴とし、未治療のまま放置すると睡眠パターンの分断やその後の健康合併症につながります。この市場には、睡眠時無呼吸症候群の診断、モニタリング、治療を目的とした幅広い機器が含まれ、世界中の患者の多様なニーズに対応しています。この市場の成長を支える主な原動力の1つは、ヘルスケア専門家と一般住民の両方における睡眠時無呼吸症候群に対する意識の高まりです。

認知度が高まるにつれ、効果的な診断ツールや治療オプションに対する需要も高まっています。技術の進歩もまた、市場の展望を形成する上で極めて重要な役割を果たしており、持続的気道陽圧(CPAP)装置が標準的な治療手段として台頭してきています。これらの装置は、加圧された空気をマスクを通して送り込むことで、睡眠中に気道を開いた状態に保つ働きをします。しかし、ウェアラブルで携帯可能なCPAP装置の開発など、装置の設計や機能の革新により、治療へのアクセスや患者のコンプライアンスが拡大しました。

家庭用睡眠時無呼吸検査キットや携帯型睡眠ポリグラフ装置などの高度な診断装置の登場により、早期発見と個別化された治療アプローチが容易になった。また、M&A、製品上市、ヘルスケア機関との提携など、主要市場プレーヤーが戦略的イニシアチブをとっていることも、市場成長をさらに刺激すると予想されます。こうした有望な見通しにもかかわらず、規制上のハードル、患者の治療へのアドヒアランスの制限、機器の高コストといった課題は、市場の成長をある程度阻害する可能性があります。

主な市場促進要因

睡眠時無呼吸症候群の有病率の増加

機器設計の技術的進歩

在宅睡眠検査デザインに対する需要の高まり

主な市場課題

患者の治療継続率の低下

デバイスの高コストと保険適用の制限

ヘルスケア提供者の認識とトレーニングの欠如

主な市場動向

個別化医療と精密治療

在宅睡眠検査の成長

セグメント別洞察

タイプ別洞察

エンドユーザー別洞察

地域別洞察

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 睡眠時無呼吸用デバイスの世界市場展望

  • 市場規模予測
    • 金額別
  • 市場シェア予測
    • タイプ別(治療デバイス、診断デバイス)
    • 適応症別(閉塞性睡眠時無呼吸症候群、中枢性睡眠時無呼吸症候群)
    • エンドユーザー別(病院、クリニック、在宅医療現場)
    • 企業別(2023年)
    • 地域別
  • 市場マップ

第6章 北米の睡眠時無呼吸用デバイス市場展望

  • 市場規模予測
    • 金額別
  • 市場シェア予測
    • タイプ別
    • 適応症タイプ別
    • エンドユーザー別
    • 国別
  • 北米:国別分析
    • 米国
    • メキシコ
    • カナダ

第7章 欧州の睡眠時無呼吸用デバイス市場展望

  • 市場規模予測
    • 金額別
  • 市場シェア予測
    • タイプ別
    • 適応症タイプ別
    • エンドユーザー別
    • 国別
  • 欧州国別分析
    • フランス
    • ドイツ
    • 英国
    • イタリア
    • スペイン

第8章 アジア太平洋の睡眠時無呼吸用デバイス市場展望

  • 市場規模予測
    • 金額別
  • 市場シェア予測
    • タイプ別
    • 適応症タイプ別
    • エンドユーザー別
    • 国別
  • アジア太平洋地域国別分析
    • 中国
    • インド
    • 韓国
    • 日本
    • オーストラリア

第9章 南米の睡眠時無呼吸用デバイス市場展望

  • 市場規模予測
    • 金額別
  • 市場シェア予測
    • タイプ別
    • 適応症タイプ別
    • エンドユーザー別
    • 国別
  • 南米:国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第10章 中東・アフリカの睡眠時無呼吸用デバイス市場展望

  • 市場規模予測
    • 金額別
  • 市場シェア予測
    • タイプ別
    • 適応症別
    • エンドユーザー別
    • 国別
  • MEA:国別分析
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • エジプト
    • トルコ

第11章 市場力学

  • 促進要因
  • 課題

第12章 市場動向と発展

  • 合併買収(もしあれば)
  • 製品上市(もしあれば)
  • 最近の動向

第13章 ポーターのファイブフォース分析

  • 業界内の競合
  • 新規参入の可能性
  • サプライヤーの力
  • 顧客の力
  • 代替品の脅威

第14章 競合情勢

  • ResMed Inc
  • Fisher Paykel Healthcare Limited
  • Koninklijke Philips N.V
  • Invacare Corporation.
  • Oventus Medical Ltd
  • Teleflex Incorporated
  • ZOLL Medical Corporation
  • SomnoMed Limited
  • Compumedics Limited.
  • Drive DeVilbiss International

第15章 戦略的提言

第16章 免責事項

目次
Product Code: 7715

Global Sleep Apnea Device Market was valued at USD 4.63 Billion in 2023 and is anticipated to project robust growth in the forecast period with a CAGR of 6.53% through 2029. The Global Sleep Apnea Device Market is a burgeoning sector within the broader medical devices industry, aimed at addressing the prevalent sleep disorder known as sleep apnea. Sleep apnea is characterized by interruptions in breathing during sleep, leading to fragmented sleep patterns and subsequent health complications if left untreated. This market encompasses a wide range of devices designed to diagnose, monitor, and treat sleep apnea, catering to the diverse needs of patients worldwide. One of the key driving factors behind the growth of this market is the increasing awareness of sleep apnea among both healthcare professionals and the general population.

As awareness grows, so does the demand for effective diagnostic tools and treatment options. Technological advancements have also played a pivotal role in shaping the market landscape, with continuous positive airway pressure (CPAP) devices emerging as a standard treatment modality. These devices work by delivering pressurized air through a mask, thereby keeping the airway open during sleep. However, innovations in device design and functionality, such as the development of wearable and portable CPAP devices, have expanded treatment accessibility and compliance among patients.

The advent of advanced diagnostic devices, including home sleep apnea testing kits and portable polysomnography devices, has facilitated early detection and personalized treatment approaches. Also, strategic initiatives undertaken by key market players, including mergers and acquisitions, product launches, and collaborations with healthcare organizations, are expected to further stimulate market growth. Despite these promising prospects, challenges such as regulatory hurdles, limited patient adherence to treatment, and the high cost of devices could impede market growth to some extent.

Key Market Drivers

Increasing Prevalence of Sleep Apnea

Sleep apnea, a disorder characterized by interrupted breathing during sleep, is garnering increasing attention globally due to its prevalence and associated health risks. As awareness grows, so does the demand for effective treatment options, propelling the global sleep apnea device market to new heights. One of the primary factors driving the growth of the global sleep apnea device market is the escalating prevalence of sleep apnea worldwide. With changing lifestyles, including sedentary habits, poor dietary choices, and increasing obesity rates, the incidence of sleep apnea has surged. Further to that, aging populations and the rise in chronic health conditions such as hypertension and diabetes further contribute to the prevalence of sleep apnea.

Heightened awareness and improved diagnosis techniques have led to more individuals seeking treatment for sleep apnea. As people become more educated about the potential consequences of untreated sleep apnea, they are increasingly inclined to undergo sleep studies and seek appropriate interventions.

In response to this growing demand, the global sleep apnea device market has witnessed a surge in innovation and technological advancements. Manufacturers are continuously developing new and improved devices to cater to the diverse needs of patients. These devices range from continuous positive airway pressure (CPAP) machines, which remain the gold standard in treatment, to oral appliances and innovative implantable devices. Advancements such as smaller, quieter, and more comfortable devices enhance patient compliance and satisfaction, further driving market growth.

Favorable reimbursement policies and increased healthcare expenditure in many regions facilitate broader access to sleep apnea diagnosis and treatment, fueling market expansion. The COVID-19 pandemic has also contributed to the growth of the sleep apnea device market, albeit indirectly. The pandemic has highlighted the importance of respiratory health, leading to heightened awareness of conditions such as sleep apnea, which can exacerbate respiratory issues. As well, disruptions in sleep patterns due to stress and lifestyle changes during the pandemic have further underscored the significance of addressing sleep disorders.

Technological Advancements in Device Design

Technological advancements in device design have become a significant catalyst for the growth of the global sleep apnea device market. As innovation continues to drive improvements in efficacy, comfort, and convenience, more individuals are seeking and adhering to sleep apnea treatment, thereby expanding the market. One of the key areas of innovation in sleep apnea device design is miniaturization and portability. Traditional CPAP machines were often bulky and cumbersome, which could deter patients from consistent use. However, advancements in engineering have led to the development of smaller, more lightweight CPAP devices that are easier to transport and less intrusive during sleep. These portable devices allow users to maintain their sleep apnea therapy regimen even while traveling, increasing compliance and improving treatment outcomes.

Technological advancements have led to the integration of smart features into sleep apnea devices. Many modern devices are equipped with wireless connectivity, allowing for remote monitoring of usage data by healthcare providers. This data can be used to track patient compliance, adjust therapy settings remotely, and identify potential issues in real-time, enhancing the overall management of sleep apnea.

Improved comfort features have been a focal point of device design innovation. Innovations such as quieter operation, reduced mask leakage, and adjustable pressure settings contribute to a more comfortable experience for users, encouraging long-term adherence to therapy. Some devices even incorporate advanced algorithms that adapt therapy pressure based on individual breathing patterns throughout the night, further optimizing treatment efficacy.

The integration of biometric sensors and data analytics into sleep apnea devices holds promise for personalized medicine and predictive healthcare. These technologies can provide insights into sleep quality, respiratory events, and overall health metrics, enabling tailored treatment plans and early detection of potential complications.

Rising Demand for Home Sleep Testing Design

The global sleep apnea device market is experiencing a significant boost due to the rising demand for home sleep testing (HST) designs. Home sleep testing offers numerous advantages over traditional in-lab polysomnography, including convenience, cost-effectiveness, and accessibility, which are driving its increasing adoption and, consequently, the growth of the market. One of the primary factors contributing to the popularity of home sleep testing is its convenience. Unlike in-lab testing, which requires patients to spend a night in a sleep clinic, HST allows individuals to undergo testing in the comfort of their own homes. This convenience eliminates the need for travel and overnight stays, reducing disruptions to daily routines and enhancing patient comfort and compliance.

Home sleep testing designs are often more cost-effective compared to in-lab polysomnography. The lower overhead costs associated with conducting tests at home translate to lower expenses for patients and healthcare providers alike. This affordability makes sleep apnea testing more accessible to a broader range of individuals, including those who may have been deterred by the higher costs of in-lab testing.

Advancements in technology have improved the accuracy and reliability of home sleep testing devices. Modern HST devices are equipped with sophisticated sensors and algorithms that can accurately detect respiratory events, monitor sleep patterns, and assess overall sleep quality. These technological enhancements ensure that home sleep testing results are comparable to those obtained through in-lab polysomnography, providing clinicians with valuable diagnostic information for effective treatment planning.

The increasing prevalence of sleep apnea and growing awareness of its health implications have also fueled the demand for home sleep testing. As more people become aware of the signs and symptoms of sleep apnea, there is a growing need for convenient and accessible diagnostic solutions. Home sleep testing addresses this need by offering a convenient and non-invasive method for diagnosing sleep apnea, leading to increased testing rates and, consequently, driving the growth of the global sleep apnea device market.

Key Market Challenges

Limited Patient Adherence to Treatment

Despite the effectiveness of sleep apnea devices in managing the condition, many patients struggle with adherence to treatment regimens. Factors such as discomfort from wearing masks, noise generated by CPAP machines, and difficulty adjusting to therapy contribute to poor patient compliance. Besides, misconceptions about the severity of sleep apnea and the perceived inconvenience of treatment further deter patients from using sleep apnea devices consistently. Addressing these adherence challenges requires a multi-faceted approach, including patient education, device optimization, and ongoing support from healthcare providers.

High Cost of Devices and Limited Insurance Coverage

The high cost of sleep apnea devices poses a significant barrier to market growth, particularly in regions with limited healthcare resources and insurance coverage. CPAP machines and other sleep apnea devices can be expensive, making them inaccessible to individuals with lower socioeconomic status. Besides, the lack of comprehensive insurance coverage for sleep apnea diagnosis and treatment further exacerbates affordability issues for patients. As a result, many individuals forego or delay seeking treatment, leading to undiagnosed and untreated cases of sleep apnea. Addressing affordability concerns through innovative pricing strategies and expanded insurance coverage is essential to improving patient access to sleep apnea devices.

Lack of Healthcare Provider Awareness and Training

Another challenge facing the Global Sleep Apnea Device Market is the lack of awareness and training among healthcare providers. Sleep apnea is often underdiagnosed and undertreated due to a lack of recognition and understanding among physicians and other healthcare professionals. Plus, there is a shortage of sleep medicine specialists and accredited sleep centers in many regions, further limiting access to proper diagnosis and treatment. Increasing education and training initiatives for healthcare providers on the identification, diagnosis, and management of sleep apnea can help address these knowledge gaps and improve patient outcomes.

Key Market Trends

Personalized Medicine and Precision Therapeutics

The landscape of sleep apnea treatment is undergoing a transformation, fueled by the principles of personalized medicine and precision therapeutics. As healthcare moves towards more individualized approaches, the global sleep apnea device market is experiencing a substantial boost, driven by innovations tailored to meet the unique needs of each patient.

Personalized medicine in sleep apnea revolves around the recognition that not all cases of the disorder are identical. Factors such as anatomical variations, underlying health conditions, and lifestyle factors can significantly impact treatment outcomes. Precision therapeutics, therefore, aim to deliver targeted interventions that address the specific needs of each patient.

One area where personalized medicine is making a significant impact is in the design of sleep apnea devices. Traditional continuous positive airway pressure (CPAP) machines offered a one-size-fits-all approach to treatment, often leading to poor compliance and suboptimal outcomes. However, advances in device technology now allow for customization of therapy parameters to match the individual patient's breathing patterns and comfort preferences. For example, adaptive pressure algorithms can automatically adjust airflow based on real-time feedback, ensuring optimal therapy delivery throughout the night.

Precision therapeutics in sleep apnea extend beyond device design to include complementary interventions tailored to address underlying causes and co-morbidities. For instance, oral appliances customized to fit the patient's mouth anatomy can effectively treat obstructive sleep apnea by repositioning the jaw and tongue to maintain an open airway during sleep. Surgical procedures, such as upper airway stimulation or soft tissue modification, can also be personalized based on the specific anatomical issues contributing to sleep apnea.

Advancements in diagnostic technologies are also driving the adoption of personalized medicine in sleep apnea management. High-resolution imaging techniques, genetic testing, and biomarker analysis enable clinicians to identify individual risk factors and tailor treatment strategies accordingly. By incorporating these personalized diagnostic approaches into clinical practice, healthcare providers can optimize treatment selection and improve patient outcomes.

Growth of Home Sleep Testing

The global sleep apnea device market is experiencing a remarkable surge, thanks to the growing popularity of home sleep testing (HST). This trend is revolutionizing the way sleep apnea is diagnosed and managed, leading to significant market expansion. Home sleep testing offers several advantages over traditional in-lab polysomnography, which has historically been the gold standard for diagnosing sleep apnea. One of the primary drivers of the growth of HST is its convenience. Unlike in-lab testing, which requires patients to spend a night in a sleep clinic, HST allows individuals to undergo testing in the comfort of their own homes. This convenience eliminates the need for travel and overnight stays, making it more appealing to patients and leading to increased testing rates.

Home sleep testing is often more cost-effective than in-lab polysomnography. The lower overhead costs associated with conducting tests at home translate to lower expenses for both patients and healthcare providers. This affordability makes sleep apnea testing more accessible to a broader range of individuals, including those who may have been deterred by the higher costs of in-lab testing.

Advancements in technology have improved the accuracy and reliability of home sleep testing devices. Modern HST devices are equipped with sophisticated sensors and algorithms that can accurately detect respiratory events, monitor sleep patterns, and assess overall sleep quality. These technological enhancements ensure that home sleep testing results are comparable to those obtained through in-lab polysomnography, providing clinicians with valuable diagnostic information for effective treatment planning.

The increasing prevalence of sleep apnea and growing awareness of its health implications have also fueled the demand for home sleep testing. As more people become aware of the signs and symptoms of sleep apnea, there is a growing need for convenient and accessible diagnostic solutions. Home sleep testing addresses this need by offering a convenient and non-invasive method for diagnosing sleep apnea, leading to increased testing rates and, consequently, driving the growth of the global sleep apnea device market.

Segmental Insights

Type Insights

Based on the Type, therapeutic devices segment emerged as the dominant segment in the global Sleep Apnea Device market in 2023.This dominance can be attributed to several key factors that underscore the significance of therapeutic devices in managing sleep apnea effectively. Firstly, therapeutic devices, particularly Continuous Positive Airway Pressure (CPAP) machines, have long been recognized as the gold standard treatment for obstructive sleep apnea (OSA). CPAP therapy works by delivering a continuous flow of pressurized air through a mask worn during sleep, preventing the collapse of the upper airway and maintaining unobstructed breathing.The growing prevalence of sleep apnea and the increasing awareness of its associated health risks have driven the demand for therapeutic devices. As more individuals are diagnosed with sleep apnea and seek treatment, the market for therapeutic devices continues to expand.

End User Insights

Based on the End User, homecare settings segment emerged as the dominant segment in the global Sleep Apnea Device market in 2023.Technological advancements in sleep apnea devices have revolutionized home-based treatment options, making them more effective and accessible for patients. Portable and user-friendly devices, including CPAP machines and home sleep testing kits, empower individuals to monitor their condition and initiate therapy conveniently, eliminating the need for frequent visits to healthcare facilities. Also, the incorporation of wireless connectivity and telemedicine capabilities into sleep apnea devices facilitates remote monitoring and support, bolstering patient engagement and satisfaction.

Favorable reimbursement policies for home-based sleep apnea treatment have incentivized healthcare providers to prescribe sleep apnea devices for use in homecare settings. Reimbursement for home sleep testing and CPAP therapy not only promotes patient compliance but also ensures access to affordable treatment options, thereby driving adoption and utilization of these devices.

Regional Insights

North America emerged as the dominant region in the Global Sleep Apnea Device Market in 2023, holding the largest market share.North America has one of the highest prevalence rates of sleep apnea globally, with millions of individuals affected by the disorder. Factors such as obesity, sedentary lifestyles, and aging populations contribute to the high incidence of sleep apnea in the region. As a result, there is a substantial demand for sleep apnea diagnosis and treatment solutions, driving market growth. Advanced Healthcare Infrastructure: North America boasts a well-developed healthcare infrastructure, comprising state-of-the-art medical facilities, research institutions, and skilled healthcare professionals. This advanced healthcare system facilitates early detection, diagnosis, and management of sleep apnea, leading to greater adoption of sleep apnea devices in clinical settings and homecare environments.

Key Market Players

ResMed Inc.

Koninklijke Philips N.V.

Fisher Paykel Healthcare Limited

Invacare Corporation

Oventus Medical Ltd.

Teleflex Incorporated

ZOLL Medical Corporation

SomnoMed Limited

Compumedics Limited

Drive DeVilbiss International

Report Scope:

In this report, the Global Sleep Apnea Device Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Global Sleep Apnea Device Market,By Type:

  • Therapeutic Devices
  • Diagnostic Devices

Global Sleep Apnea Device Market,By Indication Type:

  • Obstructive Sleep Apnea
  • Central Sleep Apnea

Global Sleep Apnea Device Market,End User:

  • Hospital Clinics
  • Homecare Settings

Global Sleep Apnea Device Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Turkey

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Sleep Apnea Device Market.

Available Customizations:

Global Sleep Apnea Device Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1.Product Overview

  • 1.1.Market Definition
  • 1.2.Scope of the Market
    • 1.2.1.Markets Covered
    • 1.2.2.Years Considered for Study
    • 1.2.3.Key Market Segmentations

2.Research Methodology

  • 2.1.Objective of the Study
  • 2.2.Baseline Methodology
  • 2.3.Key Industry Partners
  • 2.4.Major Association and Secondary Sources
  • 2.5.Forecasting Methodology
  • 2.6.Data Triangulation Validation
  • 2.7.Assumptions and Limitations

3.Executive Summary

  • 3.1.Overview of the Market
  • 3.2.Overview of Key Market Segmentations
  • 3.3.Overview of Key Market Players
  • 3.4.Overview of Key Regions/Countries
  • 3.5.Overview of Market Drivers, Challenges, and Trends

4.Voice of Customer

5.Global Sleep Apnea Device Market Outlook

  • 5.1.Market Size Forecast
    • 5.1.1.By Value
  • 5.2.Market Share Forecast
    • 5.2.1.By Type (Therapeutic Devices, Diagnostic Devices)
      • 5.2.1.1. By Therapeutic Devices (CPAP, APAP, Facial Interfaces, Oral Appliances, Adaptive Servo-Ventilators, Others)
      • 5.2.1.2. By Diagnostic Devices (Polysomnography Devices, Home Sleep Testing Devices, Sleep Screening Devices, Oximeters, Others)
    • 5.2.2.By Indication Type (Obstructive Sleep Apnea, Central Sleep Apnea)
    • 5.2.3.By End User (Hospitals Clinics, Homecare Settings)
    • 5.2.4.By Company (2023)
    • 5.2.5.By Region
  • 5.3.Market Map

6.North America Sleep Apnea Device Market Outlook

  • 6.1.Market Size Forecast
    • 6.1.1.By Value
  • 6.2.Market Share Forecast
    • 6.2.1.By Type
    • 6.2.2.By Indication Type
    • 6.2.3.By End User
    • 6.2.4.By Country
  • 6.3.North America: Country Analysis
    • 6.3.1.United States Sleep Apnea Device Market Outlook
      • 6.3.1.1.Market Size Forecast
        • 6.3.1.1.1.By Value
      • 6.3.1.2.Market Share Forecast
        • 6.3.1.2.1.By Type
        • 6.3.1.2.2.By Indication Type
        • 6.3.1.2.3.By End User
    • 6.3.2.Mexico Sleep Apnea Device Market Outlook
      • 6.3.2.1.Market Size Forecast
        • 6.3.2.1.1.By Value
      • 6.3.2.2.Market Share Forecast
        • 6.3.2.2.1.By Type
        • 6.3.2.2.2.By Indication Type
        • 6.3.2.2.3.By End User
    • 6.3.3.Canada Sleep Apnea Device Market Outlook
      • 6.3.3.1.Market Size Forecast
        • 6.3.3.1.1.By Value
      • 6.3.3.2.Market Share Forecast
        • 6.3.3.2.1.By Type
        • 6.3.3.2.2.By Indication Type
        • 6.3.3.2.3.By End User

7.Europe Sleep Apnea Device Market Outlook

  • 7.1.Market Size Forecast
    • 7.1.1.By Value
  • 7.2.Market Share Forecast
    • 7.2.1.By Type
    • 7.2.2.By Indication Type
    • 7.2.3.By End User
    • 7.2.4.By Country
  • 7.3.Europe: Country Analysis
    • 7.3.1.France Sleep Apnea Device Market Outlook
      • 7.3.1.1.Market Size Forecast
        • 7.3.1.1.1.By Value
      • 7.3.1.2.Market Share Forecast
        • 7.3.1.2.1.By Type
        • 7.3.1.2.2.By Indication Type
        • 7.3.1.2.3.By End User
    • 7.3.2.Germany Sleep Apnea Device Market Outlook
      • 7.3.2.1.Market Size Forecast
        • 7.3.2.1.1.By Value
      • 7.3.2.2.Market Share Forecast
        • 7.3.2.2.1.By Type
        • 7.3.2.2.2.By Indication Type
        • 7.3.2.2.3.By End User
    • 7.3.3.United Kingdom Sleep Apnea Device Market Outlook
      • 7.3.3.1.Market Size Forecast
        • 7.3.3.1.1.By Value
      • 7.3.3.2.Market Share Forecast
        • 7.3.3.2.1.By Type
        • 7.3.3.2.2.By Indication Type
        • 7.3.3.2.3.By End User
    • 7.3.4.Italy Sleep Apnea Device Market Outlook
      • 7.3.4.1.Market Size Forecast
        • 7.3.4.1.1.By Value
      • 7.3.4.2.Market Share Forecast
        • 7.3.4.2.1.By Type
        • 7.3.4.2.2.By Indication Type
        • 7.3.4.2.3.By End User
    • 7.3.5.Spain Sleep Apnea Device Market Outlook
      • 7.3.5.1.Market Size Forecast
        • 7.3.5.1.1.By Value
      • 7.3.5.2.Market Share Forecast
        • 7.3.5.2.1.By Type
        • 7.3.5.2.2.By Indication Type
        • 7.3.5.2.3.By End User

8.Asia-Pacific Sleep Apnea Device Market Outlook

  • 8.1.Market Size Forecast
    • 8.1.1.By Value
  • 8.2.Market Share Forecast
    • 8.2.1.By Type
    • 8.2.2.By Indication Type
    • 8.2.3.By End User
    • 8.2.4.By Country
  • 8.3.Asia-Pacific: Country Analysis
    • 8.3.1.China Sleep Apnea Device Market Outlook
      • 8.3.1.1.Market Size Forecast
        • 8.3.1.1.1.By Value
      • 8.3.1.2.Market Share Forecast
        • 8.3.1.2.1.By Type
        • 8.3.1.2.2.By Indication Type
        • 8.3.1.2.3.By End User
    • 8.3.2.India Sleep Apnea Device Market Outlook
      • 8.3.2.1.Market Size Forecast
        • 8.3.2.1.1.By Value
      • 8.3.2.2.Market Share Forecast
        • 8.3.2.2.1.By Type
        • 8.3.2.2.2.By Indication Type
        • 8.3.2.2.3.By End User
    • 8.3.3.South Korea Sleep Apnea Device Market Outlook
      • 8.3.3.1.Market Size Forecast
        • 8.3.3.1.1.By Value
      • 8.3.3.2.Market Share Forecast
        • 8.3.3.2.1.By Type
        • 8.3.3.2.2.By Indication Type
        • 8.3.3.2.3.By End User
    • 8.3.4.Japan Sleep Apnea Device Market Outlook
      • 8.3.4.1.Market Size Forecast
        • 8.3.4.1.1.By Value
      • 8.3.4.2.Market Share Forecast
        • 8.3.4.2.1.By Type
        • 8.3.4.2.2.By Indication Type
        • 8.3.4.2.3.By End User
    • 8.3.5.Australia Sleep Apnea Device Market Outlook
      • 8.3.5.1.Market Size Forecast
        • 8.3.5.1.1.By Value
      • 8.3.5.2.Market Share Forecast
        • 8.3.5.2.1.By Type
        • 8.3.5.2.2.By Indication Type
        • 8.3.5.2.3.By End User

9.South America Sleep Apnea Device Market Outlook

  • 9.1.Market Size Forecast
    • 9.1.1.By Value
  • 9.2.Market Share Forecast
    • 9.2.1.By Type
    • 9.2.2.By Indication Type
    • 9.2.3.By End User
    • 9.2.4.By Country
  • 9.3.South America: Country Analysis
    • 9.3.1.Brazil Sleep Apnea Device Market Outlook
      • 9.3.1.1.Market Size Forecast
        • 9.3.1.1.1.By Value
      • 9.3.1.2.Market Share Forecast
        • 9.3.1.2.1.By Type
        • 9.3.1.2.2.By Indication Type
        • 9.3.1.2.3.By End User
    • 9.3.2.Argentina Sleep Apnea Device Market Outlook
      • 9.3.2.1.Market Size Forecast
        • 9.3.2.1.1.By Value
      • 9.3.2.2.Market Share Forecast
        • 9.3.2.2.1.By Type
        • 9.3.2.2.2.By Indication Type
        • 9.3.2.2.3.By End User
    • 9.3.3.Colombia Sleep Apnea Device Market Outlook
      • 9.3.3.1.Market Size Forecast
        • 9.3.3.1.1.By Value
      • 9.3.3.2.Market Share Forecast
        • 9.3.3.2.1.By Type
        • 9.3.3.2.2.By Indication Type
        • 9.3.3.2.3.By End User

10.Middle East and Africa Sleep Apnea Device Market Outlook

  • 10.1.Market Size Forecast
    • 10.1.1.By Value
  • 10.2.Market Share Forecast
    • 10.2.1.By Type
    • 10.2.2.By Indication Type
    • 10.2.3.By End User
    • 10.2.4.By Country
  • 10.3.MEA: Country Analysis
    • 10.3.1.South Africa Sleep Apnea Device Market Outlook
      • 10.3.1.1.Market Size Forecast
        • 10.3.1.1.1.By Value
      • 10.3.1.2.Market Share Forecast
        • 10.3.1.2.1.By Type
        • 10.3.1.2.2.By Indication Type
        • 10.3.1.2.3.By End User
    • 10.3.2.Saudi Arabia Sleep Apnea Device Market Outlook
      • 10.3.2.1.Market Size Forecast
        • 10.3.2.1.1.By Value
      • 10.3.2.2.Market Share Forecast
        • 10.3.2.2.1.By Type
        • 10.3.2.2.2.By Indication Type
        • 10.3.2.2.3.By End User
    • 10.3.3.UAE Sleep Apnea Device Market Outlook
      • 10.3.3.1.Market Size Forecast
        • 10.3.3.1.1.By Value
      • 10.3.3.2.Market Share Forecast
        • 10.3.3.2.1.By Type
        • 10.3.3.2.2.By Indication Type
        • 10.3.3.2.3.By End User
    • 10.3.4.Egypt Sleep Apnea Device Market Outlook
      • 10.3.4.1.Market Size Forecast
        • 10.3.4.1.1.By Value
      • 10.3.4.2.Market Share Forecast
        • 10.3.4.2.1.By Type
        • 10.3.4.2.2.By Indication Type
        • 10.3.4.2.3.By End User
    • 10.3.5.Turkey Sleep Apnea Device Market Outlook
      • 10.3.5.1.Market Size Forecast
        • 10.3.5.1.1.By Value
      • 10.3.5.2.Market Share Forecast
        • 10.3.5.2.1.By Type
        • 10.3.5.2.2.By Indication Type
        • 10.3.5.2.3.By End User

11.Market Dynamics

  • 11.1.Drivers
  • 11.2.Challenges

12.Market Trends Developments

  • 12.1.Merger Acquisition (If Any)
  • 12.2.Product Launches (If Any)
  • 12.3.Recent Developments

13.Porters Five Forces Analysis

  • 13.1.Competition in the Industry
  • 13.2.Potential of New Entrants
  • 13.3.Power of Suppliers
  • 13.4.Power of Customers
  • 13.5.Threat of Substitute Products

14.Competitive Landscape

  • 14.1.ResMed Inc
    • 14.1.1.Business Overview
    • 14.1.2.Company Snapshot
    • 14.1.3.Products Services
    • 14.1.4.Financials (As Reported)
    • 14.1.5.Recent Developments
    • 14.1.6.Key Personnel Details
    • 14.1.7.SWOT Analysis
  • 14.2.Fisher Paykel Healthcare Limited
  • 14.3.Koninklijke Philips N.V
  • 14.4.Invacare Corporation.
  • 14.5.Oventus Medical Ltd
  • 14.6.Teleflex Incorporated
  • 14.7.ZOLL Medical Corporation
  • 14.8.SomnoMed Limited
  • 14.9.Compumedics Limited.
  • 14.10.Drive DeVilbiss International

15.Strategic Recommendations

16.About Us Disclaimer